Duloxetine for pathological laughing and crying

International Journal of Neuropsychopharmacology

Volumn 12, Issue 10, 2009, Pages 1429-1430

  Ferentinos, Panagiotis ^a   Paparrigopoulos, Thomas ^a   Rentzos, Michael ^a   Evdokimidis, Ioannis ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; DEXTROMETHORPHAN; DULOXETINE; LAMOTRIGINE; LEVODOPA; METHYLPHENIDATE; NORTRIPTYLINE; QUINIDINE; SEROTONIN UPTAKE INHIBITOR; VENLAFAXINE; THIOPHENE DERIVATIVE;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; CASE REPORT; CLINICAL FEATURE; DEPRESSION; DISEASE SEVERITY; DRUG EFFICACY; DRUG MECHANISM; DRUG WITHDRAWAL; FEMALE; HUMAN; LETTER; MENTAL INSTABILITY; PATHOGENESIS; PATHOLOGICAL CRYING; PATHOLOGICAL LAUGHING AND CRYING; PATHOLOGICAL LAUGHTER; PRIORITY JOURNAL; RATING SCALE; SOCIAL ISOLATION; TREATMENT OUTCOME; CRYING; EMOTIONAL DISORDER; MIDDLE AGED; NONVERBAL COMMUNICATION; PHYSIOLOGY;

AFFECTIVE SYMPTOMS; AMYOTROPHIC LATERAL SCLEROSIS; CRYING; FEMALE; HUMANS; LAUGHTER; MIDDLE AGED; THIOPHENES;

EID: 77954063349     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145709990745     Document Type: Letter

References (10)

1. Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron Diseases (2000). El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 1, 293-299.
2. Kim SW, Shin IS, Kim JM, Lim SY, et al. (2005). Mirtazapine treatment for pathological laughing and crying after stroke. Clinical Neuropharmacology 28, 249-251.
3. Moore SR, Gresham LS, Bromberg MB, Kasarkis EJ, Smith RA (1997). A self report measure of affective lability. Journal of Neurology, Neurosurgery and Psychiatry 63, 89-93. (Pubitemid 27317366)
4. Nahas Z, Arlinghaus KA, Kotrla KJ, Clearman RR, George MS (1998). Rapid response of emotional incontinence to selective serotonin reuptake inhibitors. Journal of Neuropsychiatry and Clinical Neurosciences 10, 453-455. (Pubitemid 28505398)
5. Ramasubbu R (2003). Lamotrigine treatment for post-stroke pathological laughing and crying. Clinical Neuropharmacology 26, 233-235. (Pubitemid 37221633)
6. Robinson RG, Parikh RM, Lipsey JR, Starkstein SE, Price TR (1993). Pathological laughing and crying following stroke: validation of a measurement scale and a double-blind treatment study. American Journal of Psychiatry 150, 286-293. (Pubitemid 23046517)
7. Rosen H (2008). Dextromethorphan/quinidine sulfate for pseudobulbar affect. Drugs Today (Barcelona) 44, 661-668.
8. Smith AG, Montealegre-Orjuela M, Douglas JE, Jenkins EA (2003). Venlafaxine for pathological crying after stroke. Journal of Clinical Psychiatry 64, 731-732.
9. Udaka F, Yamao S, Nagata H, Nakamura S, Kameyama M (1984). Pathologic laughing and crying treated with levodopa. Archives of Neurology 41, 1095-1096. (Pubitemid 14041755)
10. Wortzel HS, Oster TJ, Anderson CA, Arciniegas DB (2008). Pathological laughing and crying: epidemiology, pathophysiology and treatment. CNS Drugs 22, 531-545. (Pubitemid 351822116)